Assay May Target Early Lung Cancers for Adjuvant Therapy

LOS ANGELES (IMNG) - A novel genetic assay helps identify patients with early, aggressive lung cancer who might benefit from adjuvant therapy.The assay, marketed as Pervino Lung RS by Life Technologies,...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news